Kevin Patrick Danahy, Chief Officer of Pulse Biosciences PLSE, has filed 3 purchases and 10 sales on the open market. Over the past 12 months that comes to a net sale of $3M. The latest trade was on 02/18.

KD

KD

Kevin Patrick Danahy

Chief Commercial Officer

Company

Pulse Biosciences PLSE

First filing

23/03/24

Trades

42 trades

Buys / sales

3 / 10

12-month net buying

−$3M

Last trade

02/18

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Pulse BiosciencesPLSE	Open-market sale10b5-1 plan	02/18	02/23	5,000 sh	$23.64	$118,200	−10.4%
Pulse BiosciencesPLSE	Open-market sale10b5-1 plan	02/12–02/17	02/17	60,000 sh3 trades	$23.51avg.	$1,410,600	−58.1%
Pulse BiosciencesPLSE	Open-market sale10b5-1 plan	02/09–02/11	02/11	60,000 sh3 trades	$23.39avg.	$1,403,400	−58.1%
Pulse BiosciencesPLSE	Open-market sale10b5-1 plan	25/10/02	25/10/07	4,600 sh	$18.53	$85,238	−9.6%
Pulse BiosciencesPLSE	Open-market sale10b5-1 plan	25/09/18–25/09/19	25/09/22	20,400 sh2 trades	$18.49avg.	$377,192	−32.0%
Pulse BiosciencesPLSE	Open-market buy	23/11/16	23/11/17	5,393 sh3 trades	$6.52avg.	$35,156.12	+17.7%